Kirin Brewery Company is spending $1.2 billion to buy Australia’s most trusted brand for vitamins and nutritional supplements, Blackmores. The Japanese brewer agreed to acquire the vitamin maker as part of its plans to expand its business into healthcare.
BBC News reported that Kirin Brewery is venturing into other business fields as beer sales in Japan are falling. Regulation of alcohol is also becoming tighter, so it needs another profit driver.
The World Health Organization (WHO) wants stricter rules to be implemented for the global alcohol sector. The organization has been calling on governments to establish higher prices for their alcoholic beverage products to dissuade people from drinking.
Coupled with the declining sales, this is why Kirin is trying to get into new businesses. In fact, this deal is the brand’s latest move in its efforts to diversify and move away from the alcohol business.
Kirin Brewery secured unanimous approval from Blackmores’ company board as it was offered an AU$95 per share, and it will pay its shareholders an AU$3.34 special dividend, according to The Japan Times. The acquisition will also save the vitamin company, which has been struggling to recover after being dampened by the COVID-19 pandemic.
The buyout deal between Blackmores and Kirin Brewery is expected to be completed this coming August. It was shared that this agreement is also supported by the Australian company’s founder’s son, Marcus Blackmore, who holds an 18% stake.
The announcement of the deal was received positively by the business community as Blackmores’ shares shot up to more than 20%. This is said to be the firm’s highest gain in more than seven years.
"The acquisition of Blackmores is highly complementary to our existing Health Science business," Kirin Brewery said in a statement. The chairwoman of Blackmores, Wendy Stops, also commented that Kirin’s deal “represents an attractive, all-cash transaction."
Photo by: Johnny Silvercloud/Flickr (CC BY-SA 2.0)


U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
BOJ Poised for Historic Rate Hike as Japan Signals Shift Toward Monetary Normalization
New Zealand Business Confidence Hits 30-Year High as Economic Outlook Improves
Canada Signals Delay in US Tariff Deal as Talks Shift to USMCA Review
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
U.S. Stocks End Week Higher as Tech Rally Offsets Consumer Weakness
U.S. Stock Futures Edge Higher as Micron Earnings Boost AI Sentiment Ahead of CPI Data
Asian Fund Managers Turn More Optimistic on Growth but Curb Equity Return Expectations: BofA Survey
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
RBA Unlikely to Cut Interest Rates in 2026 as Inflation Pressures Persist, Says Westpac
Japan Exports to U.S. Rebound in November as Tariff Impact Eases, Boosting BOJ Rate Hike Expectations
BoE Set to Cut Rates as UK Inflation Slows, but Further Easing Likely Limited
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Yen Near Lows as Markets Await Bank of Japan Rate Decision, Euro Slips After ECB Signals Caution
Oil Prices Steady in Asia but Headed for Weekly Loss on Supply Glut Concerns
Dollar Holds Firm Ahead of Global Central Bank Decisions as Yen, Sterling and Euro React 



